Novartis
Search results
Sandoz is a global leader in generic pharmaceuticals and biosimilars, with a mission to discover new ways to improve and extend people's lives. Learn more about our products, our quality standards, our innovation and sustainability efforts, and our partnerships and collaborations.
The company was founded in 1886 by Alfred Kern (1850–1893) and Edouard Sandoz (1853–1928) in Basel (Switzerland) under the name Chemiefirma Kern und Sandoz. Initially the company focused on production of dyes namely alizarin blue and auramine .
<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-PVQMF29>m_auth=>m_preview=>m_cookies_win=x" height="0" width="0" style="display:none;visibility ...
Our Sandoz Division is a global leader in generic medicines and biosimilars, offering more than 1,000 different types of high-quality, affordable products across a broad range of therapeutic areas. It pioneers new ways to help people around the world access high-quality medicines.
Oct 4, 2023 · Sandoz plans move to new central Basel headquarters by mid-2024, following proposed spin-off as standalone company. The Sandoz AG headquarters plans to move to a landmark office building called “Elsässertor” in the center of Basel, right by the Basel SBB train station.
Sandoz | 923,890 followers on LinkedIn. Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally.
Analyst and investor presentation. This report provides a comprehensive overview of Sandoz, including our business, strategy, governance and performance.
Oct 4, 2023 · Novartis executes separation of the Sandoz business to create an independent company by way of a 100% Spin-off; Shares of Sandoz will be listed and commence trading today on the SIX Swiss Exchange; Spin-off allows shareholders to benefit from a Novartis with capital and management attention fully focused on innovative medicines
Sandoz US is a part of a global leader in generic and biosimilar medicines, with a mission to pioneer access for patients and improve their lives.
Oct 4, 2023 · Sandoz Group AG, the maker of copycat medicines, was spun off from drugmaker Novartis AG to begin life as a standalone company on Wednesday when its shares started trading on Switzerland’s stock...
